Rates of opioid administration were found to be high in opioid-naive inpatients.
Increased risk for several neonatal, postnatal outcomes for offspring exposed to maternal migraine.
Retail customers report decreases in prescriptions, over-the-counter meds due to effectiveness of cannabis.
Patients with vs without episodic or chronic cluster headache may have reduced sleep quality.
Odds of migraine higher for food-insecure vs food-secure in unadjusted, adjusted analyses.
Orthopedic manual physical therapy, when combined with biobehavioral therapy, may not provide additional benefits to patients with chronic low back pain.
The majority of interventional spine physicians reported using magnetic resonance imaging ahead of lumbar epidural steroid injections to correlate with the physical examination.
More than half of those who misused prescription opioids in 2012 to 2014 were binge drinkers.
The use of sacroiliac joint injection with anesthetic and corticosteroid may not be efficacious for sacroiliac joint pain.
Patients who decreased opioid use while undergoing basivertebral nerve ablation were found to experience greater relief of chronic low back pain than those who increased opioid use.
The prevalence of cluster headache may be higher in individuals with a substance use disorder than in the general population.
Poor outcomes seen in pregnancy for women and at birth, neonatal, and postnatal periods for infants.
During a migraine attack, experiencing nausea with and without vomiting is associated with nonadherence to acute migraine medication guidelines.
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may represent effective migraine prophylactic treatments.
An association between migraine and metabolic syndrome was observed only in women with a past history of migraine.
16.9 percent of workers with any low back pain missed at least 1 day of work in previous 3 months.
A diagnosis of incident or new chronic pain may be twice as likely in patients with vs without gout.
Study evaluated safety profile of lasmiditan based on findings from the 2 phase 3 studies (SPARTAN and SAMURAI) for the treatment of acute migraine.
Children and adolescents undergoing infusion therapy for migraine were found to have higher levels of functional disability and a lower quality of life compared with patients not receiving infusion therapy.
The International Headache Society through roundtable discussion with stakeholders, such as the Clinical Trials and the Child and Adolescent Standing Committees, including lay people and pharmaceutical professionals, updated their guidelines for controlled trials of preventive treatment for migraines within the pediatric population.